Cargando…
Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression
Fibroblast growth factor receptor 2 (FGFR2) has been identified as a predictive biomarker for unfavorable prognosis of gastric adenocarcinoma. As a well-defined antagonist in FGFR2-induced RAS/ERK activation, ectopic expression of sprouty (SPRY) family was reported in several kinds of cancers except...
Autores principales: | Xu, Yunfei, Yang, Xiaoqing, Li, Zhen, Li, Shuo, Guo, Sen, Ismail, Sayed, Liu, Hongda, Huang, Zhihong, Zhang, Zongli, Chen, Yuxin, Sun, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354878/ https://www.ncbi.nlm.nih.gov/pubmed/28002800 http://dx.doi.org/10.18632/oncotarget.13982 |
Ejemplares similares
-
Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle
por: Qiu, Bo, et al.
Publicado: (2019) -
Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling
por: Xu, Yun‐Fei, et al.
Publicado: (2018) -
Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein
por: Gao, Xianlong, et al.
Publicado: (2017) -
Sprouty2 and Spred1-2 Proteins Inhibit the Activation of the ERK Pathway Elicited by Cyclopentenone Prostanoids
por: García-Domínguez, Carlota A., et al.
Publicado: (2011) -
Sprouty-2 Controls c-Met Expression and Metastatic Potential of Colon Cancer Cells: Sprouty/c-Met Upregulation in Human Colonic Adenocarcinomas
por: Holgren, Cory, et al.
Publicado: (2010)